Interleukin-1α release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity
Authors:
- 21 November 2024
- journal article
- Published by Elsevier in Cancer Cell
- Vol. 42 (12) , 2015-2031.e11
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (R01CA230610)
- National Cancer Institute (P30-CA076292)
- National Institutes of Health
- Cancer Research Institute
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P2ZHP3_171892)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P400PM_183881)
This publication has 74 references indexed in Scilit:
- Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancerGeroScience, 2023
- Gasdermin D restricts anti-tumor immunity during PD-L1 checkpoint blockadeCell Reports, 2022
- Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseasesAutoimmunity Reviews, 2021
- Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon CancerCell, 2020
- Influenza Virus Z-RNAs Induce ZBP1-Mediated NecroptosisCell, 2020
- RIPK3 Activation Leads to Cytokine Synthesis that Continues after Loss of Cell Membrane IntegrityCell Reports, 2019
- Comprehensive Integration of Single-Cell DataCell, 2019
- A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T CellsCell, 2016
- Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic CellsCancer Cell, 2014
- Opposing effects of fibrosarcoma cell‐derived IL‐1α and IL‐1β on immune response inductionInternational Journal of Cancer, 2008